Sci-Tech Seattle
SEE OTHER BRANDS

Your best source on science and technology news from Washington state

Sci-Tech Seattle: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Seattle.

Press releases published on June 6, 2025

White Label Link Building Agency, Link.Build, Expands Digital PR Services to Meet Growing Demand for Earned Media

White Label Link Building Agency, Link.Build, Expands Digital PR Services to Meet Growing Demand for Earned Media

Link.Build introduces expanded digital PR services, combining earned media, thought leadership placements, and authority link acquisition. SEATTLE, WA, UNITED STATES, June 6, 2025 /⁨EINPresswire.com⁩/ -- Link.Build, a leading white label link building …

Concourse Hosting and GCSIT Announce Strategic Partnership

Concourse Hosting and GCSIT Announce Strategic Partnership

Concourse and GCSIT partner to offer secure, cost-effective private cloud solutions for mid-sized U.S. businesses. WA, UNITED STATES, June 6, 2025 /⁨EINPresswire.com⁩/ -- Concourse Hosting, LLC, the security-first private cloud purpose-built for business- …

Community Boss Brings Parking, Amenity, and Enforcement Solutions to Apartmentalize 2025

Community Boss Brings Parking, Amenity, and Enforcement Solutions to Apartmentalize 2025

Stop unauthorized parking, create additional revenue, manage amenity access, and enforce community rules with ease. EVERETT, WA, UNITED STATES, June 6, 2025 /⁨EINPresswire.com⁩/ -- Community Boss will be exhibiting in booth 1201 at the annual NAA …

Intel and Laplink Software, Inc. Highlight Automated PC Refresh as a Game-Changer for Overburdened IT Teams

Intel and Laplink Software, Inc. Highlight Automated PC Refresh as a Game-Changer for Overburdened IT Teams

BELLEVUE, WA, UNITED STATES, June 6, 2025 /⁨EINPresswire.com⁩/ -- As IT departments face mounting pressure to support hybrid workforces, manage outdated hardware, and navigate tightening budgets, Intel is spotlighting a strategic solution in its newly …

Agent Review Partners with TwisterIQ to Power the Future of Insurance Agent Discovery in an AI-Driven World

Agent Review Partners with TwisterIQ to Power the Future of Insurance Agent Discovery in an AI-Driven World

BELLEVUE, WA, UNITED STATES, June 6, 2025 /⁨EINPresswire.com⁩/ -- Agent Review, the leading online reputation management platform built exclusively for insurance professionals, is excited to announce a strategic partnership with TwisterIQ, a mobile-first …

Draganfly Announces Additional Exercise Of Over-Allotment Option

Draganfly Announces Additional Exercise Of Over-Allotment Option

Saskatoon, SK., June 06, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), a drone solutions, and systems developer, today announced that further to the closing of the Company’s US$3.6 million …

From Robin Hood to APT Miners: New Passive Income in the Digital Asset Era

From Robin Hood to APT Miners: New Passive Income in the Digital Asset Era

San Francisco, California, June 06, 2025 (GLOBE NEWSWIRE) -- Remember when Robinhood first became popular? When the “zero commission trading” was launched, young people flocked to the US stock market. It took only a few minutes to open an account and buy …

BlackRock® Canada Announces Changes to the iShares Jantzi Social Index ETF

BlackRock® Canada Announces Changes to the iShares Jantzi Social Index ETF

TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (“BlackRock”) (NYSE: BLK), is announcing that iShares Jantzi Social Index ETF (the “iShares …

BlackRock® Canada annonce des modifications au iShares Jantzi Social Index ETF

BlackRock® Canada annonce des modifications au iShares Jantzi Social Index ETF

TORONTO, 06 juin 2025 (GLOBE NEWSWIRE) -- Gestion d’actifs BlackRock Canada Limitée (« BlackRock Canada »), filiale en propriété exclusive indirecte de BlackRock, Inc. (« BlackRock ») (NYSE : BLK), annonce que le iShares Jantzi Social Index ETF (le « FNB  …

Digi Power X Announces Grant of Stock Options

Digi Power X Announces Grant of Stock Options

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025. MIAMI, June 06, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“ …

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today …

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …

Rakovina Therapeutics Announces the Closing of Oversubscribed Private Placement of $4.9 Million

Rakovina Therapeutics Announces the Closing of Oversubscribed Private Placement of $4.9 Million

VANCOUVER, British Columbia, June 06, 2025 (GLOBE NEWSWIRE) --  Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered …

RESTEM to Present Phase 2/3 IIMPACT Trial Design in Idiopathic Inflammatory Myopathy at EULAR 2025 Congress

RESTEM to Present Phase 2/3 IIMPACT Trial Design in Idiopathic Inflammatory Myopathy at EULAR 2025 Congress

MIAMI, June 06, 2025 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced that it will present the rationale and study design …

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, June 06, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …

PolyPid to Host Conference Call and Webcast to Discuss D-PLEX₁₀₀ SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025

PolyPid to Host Conference Call and Webcast to Discuss D-PLEX₁₀₀ SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025

PETACH TIKVA, Israel, June 06, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will host a conference call and webcast to report …

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing …

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WOBURN, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to newly …

Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference

Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference

LEXINGTON, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders …

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

Company announcement – No. 14 / 2025 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, June 6, 2025 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a biotechnology …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service